AstraZeneca’s new weight-loss pill, AZD5004, shows promise in early trials with tolerable side effects, advancing to Phase II studies focused on reducing obesity.
An analysis of U.S. health claims reveals that while GLP-1 drugs like Wegovy may aid weight loss, they significantly increase medical costs—rising to $18,507 annually—without reducing obesity-related health events, raising concerns for insurers and employers.
The CDC confirms bird flu in two Washington poultry workers and ruled out infections in Missouri healthcare staff.
Germany has detected its first case of the new mpox variant, clade 1b, in a 33-year-old man.
World Health Organization has reported over 35,000 suspected cases of mpox across Africa in 2024, with nearly 1,000 deaths potentially linked to the disease
The WHO has approved Abbott Laboratories' mpox diagnostic test for emergency use, marking a key step in boosting testing in outbreak-hit countries. The real-time PCR test detects mpox virus DNA from skin swabs, with more tests under review to increase diagnostic availability worldwide.
Researchers at the University of Oxford are developing OvarianVax, a vaccine aimed at training the immune system to detect early signs of ovarian cancer.
Rwanda is facing its first-ever outbreak of the deadly Marburg virus, with 36 cases and 11 deaths reported. WHO has classified the risk as very high in Rwanda and high across the African region. Marburg, related to Ebola, has a fatality rate that can reach 88% in severe cases.
The FDA has approved AstraZeneca's treatment for use outside of healthcare facilities, but it will still require a prescription.
The World Health Organization reports 30,000 suspected mpox cases in Africa this year, with over 800 deaths, mostly in the Democratic Republic of Congo. The World Bank is allocating $128.89 million to support ten African countries in battling the outbreak.
You can download the AnewZ application from Play Store and the App Store.
